首页> 外文会议>Society for Biomaterials annual meeting and exposition >Tissue Engineered Human Anterior Cruciate Ligament Derived Cellular Patch for Partial ACL Repair
【24h】

Tissue Engineered Human Anterior Cruciate Ligament Derived Cellular Patch for Partial ACL Repair

机译:组织工程人体前十字韧带衍生的细胞贴片用于部分ACL修复

获取原文

摘要

Our results demonstrate that hACL derived cells can be isolated and expanded, and the PLAGA patch promoted growth. This technique is a reproducible and a reliable way to provide a potential cell source for a wide array of future investigations for ACL reconstruction. Our primary direction with the hACL/2D scaffold is for the future use as a patch to augment primary repair of partial ACL tears. Our protocol would allow a combination of suture repair with a 2D scaffold that offers a delivery system for hACL derived cells into the wound site while simultaneously protecting the cells from the synovial fluid environment. This could allow functional repair and healing of a partial tear, avoiding the comorbidities associated with ACL reconstruction. This technique demonstrates promising results and future investigation will display the potential of this technique for ACL repair and reconstruction.
机译:我们的结果表明,可以分离和扩展HACL衍生细胞,并且PLAGA贴剂促进了生长。 该技术是一种可重复的和可靠的方法,可以为ACL重建提供广泛的未来研究提供潜在的细胞源。 我们与HACL / 2D脚手架的主要方向是将来用作补丁以增加部分ACL泪液的主要修复。 我们的协议将允许使用2D支架的缝合修复组合,其提供用于HACL衍生细胞的输送系统进入伤口部位,同时保护细胞免受滑膜环境。 这可能允许功能性修复和愈合部分撕裂,避免与ACL重建相关的合并症。 该技术表明了有希望的结果,未来的调查将显示该技术对ACL修复和重建的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号